LL 3858, SUDOTERB
UNII-SK2537665A;
CAS 676266-31-2;
N-[2-methyl-5-phenyl-3-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]pyrrol-1-yl]pyridine-4-carboxamide;
N-[2-Methyl-5-phenyl-3-[[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]methyl]-1H-pyrrol-1-yl]-4-pyridinecarboxamide
Sudoterb(TM)
Molecular Formula: | C29H28F3N5O |
---|---|
Molecular Weight: | 519.572 g/mol |
- Originator Lupin
- Class Antituberculars; Isonicotinic acids; Pyrroles
- Mechanism of Action Undefined mechanism
- Orphan Drug Status No
- New Molecular Entity Yes
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 23 Jul 2015 No recent reports on development identified – Phase-II for Tuberculosis in India (unspecified route)
- 11 Dec 2013 Lupin completes a phase II trial in Tuberculosis in India prior to December 2013 (CTRI2009-091-000741)
- 31 Jul 2010 Lupin completes enrolment in its phase II trial for Tuberculosis in India (CTRI2009-091-000741)
Sudoterb HCl
CAS: 1044503-04-9 (2HCl)
Chemical Formula: C29H30Cl2F3N5O
Molecular Weight: 592.4882
SYNTHESIS
Tuberculosis (TB) is a contagious disease, which usually runs a protracted course, ending in death in majority of the cases, with relapse being a common feature of the disease. It is one…
View original post 4,241 more words